Table 3 Characteristics of qualitative study participants
From: Systematic review of the use of translated patient-reported outcome measures in cancer trials
Interview group | Total | Country (n) | Additional areas of expertise/experience (n) |
|---|---|---|---|
Trialists | 10 | UK (10) | Research (10), clinical (5), Patient and Public Involvement (1), PRO expertise (2), methodologist (not PRO) (2), pharmaceutical experience (1) |
Patient representatives | 12 | UK (11) Spain (1) | Regulatory (3), clinical (1), funding panellist (5) Patient and Public Involvement (12) |
International experts | 10 | USA (7) Belgium (1) UK (1) Netherlands (1) | Regulatory (2), research (10), clinical (3) Funding panellist (4), Patient and Public Involvement (1) Journal editor (6), PRO expertise (10) Methodologist (not PRO) (6), pharmaceutical experience (4) |
Reviewers | 12 | UK (8) Canada (2) USA (1) Austria (1) | Regulatory (3), research ethics (2), research (7), clinical (7), funding panellist (5), Patient and Public Involvement (4) Journal editor (4), PRO expert (1), methodologist (not PRO) (5) |